Investments in health care facilities, diagnostic and therapeutic equipment, and information and communications technology, affect the capacity to respond to population needs. There are no guidelines or international benchmarks regarding the optimal level of capital investment in the health sector. Nonetheless, it is of critical importance for countries to maintain spare capacity to deal with surges – too little investment will over-stretch service provision, undermining health system resilience.
In 2020, the EU allocated around 0.45% of its total GDP to capital spending in the health sector (Figure 8.11). This equated to 5% of health expenditure in 2020. However, as with current spending, there are differences in levels of investment between countries and variations over time.
As a proportion of GDP, Germany was the biggest spender on capital investment in the health sector in 2020, allocating 1.1% of its GDP. At the lower end, the Czech Republic, Luxembourg, Greece and Poland all invested less than 0.2% of their GDP on capital infrastructure and equipment across the health sector.
Capital investment in buildings, machinery and technology fluctuates, responding not only to acute needs but also to the economic climate. A lack of investment spending now can lead to accumulating problems and higher future costs, as equipment and facilities deteriorate.
After decreasing significantly in the wake of the 2008‑09 economic crisis, capital spending in the health sector picked up across Europe between 2013 and 2015, before dropping back somewhat. Recent years have seen investment pick up again, on average, accelerating between 2019 and 2020, with the COVID‑19 pandemic a likely driver of this trend in some countries (Figure 8.12).
While Germany maintained a steady yet elevated level of capital investment over the last eight years, other countries displayed a more volatile pattern of spending. Spain, and outside of the EU, the United Kingdom, showed a significant increase in investment over 2019‑20. However, both countries reduced markedly their capital spending after the 2008‑09 economic crisis, such that their respective 2020 spending was still below the levels reported in 2008. While capital spending in Italy and France may have rebounded to an extent after the economic crisis, since 2013 it has not increased further (and has fallen in France), such that pre‑pandemic levels were below those of the previous 10‑15 years.
The European Union supports capital investment in national health systems via the European Structural and Investment Funds. The key objectives of the Funds are to reduce health inequalities between regions and social groups, and to increase the effectiveness and accessibility of national health care systems (European Commission, 2020[1]). Following the pandemic, investment support by the EU Funds in health is expected to increase significantly as part of the EUR 800 billion “Next Generation EU” recovery package.
